SUBSTITUIERTE PHENETHYLAMINE MIT SEROTONINERGISCHER UND/ODER NOREPINEPHRINERGISCHER AKTIVITÄT

Patent europeic · EP1954669 · Stritgà

Inscripziun en il register

Numer da publicaziun
EP1954669
Numer da la dumonda
EP06844628
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
Stritgà
Scrittira da patent
Concedì
Annunzià
30-11-2006
Publitgà
13-08-2008
Concedì
08-07-2015
Stritgà
23-06-2023
Motiv
Taxa annuala betg pajada
Classas IPC
C07C 217/74 (2006.01)
A61K 31/135 (2006.01)
A61P 25/00 (2006.01)
Prioritad
US 741315 P 01.12.2005
US 841366 P 30.08.2006
Dumonda PCT
PCT/US2006/045673 30.11.2006
Publicaziun PCT
WO2007/064697 07.06.2007
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 23-06-2023

    Stritgà, taxa betg pajada

    Published in Swissreg on 23.06.2023

  2. 07-01-2022

    Transferì

    Owner
    Auspex Pharmaceuticals, Inc., 1261 Liberty One Way, Suite C, Vista, CA 92081-8356, USA → Acadia Pharmaceuticals Inc., 12830 El Camino Real, Suite 400, San Diego, CA 92130, USA

    Published in Swissreg on 07.01.2022

  3. 08-07-2015

    Concedì

    Published in Swissreg on 08.07.2015

Partidas

Possessur

Acadia Pharmaceuticals Inc.

12830 El Camino Real, Suite 400, San Diego, CA 92130, US

Inventur

GANT, Thomas G.

Carlsbad, California 92009, US

SARSHAR, Sepehr

Cardiff By The Sea, California 92007, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.